Recently, the inaugural congress of the International Society of Obstetrics‑Gynecology Ablation (ISOGA) was successfully held in the Philippines, opening a new chapter for minimally‑invasive ablation‑based diagnosis and treatment across global obstetrics and gynecology.
Major exciting news came out of the conference. Professor Gong Xiaoming, Chief Expert at Woyi Minimally‑Non‑Invasive Medicine, has been appointed Chair of ISOGA. This honour represents high‑level recognition from the international medical community for his long‑term devotion to gynecological minimally‑ and non‑invasive therapies. It also serves as solid evidence that Chinese minimally‑invasive gynecological expertise has reached the global cutting‑edge, a well‑deserved reward for his years of dedicated research.
Since he first embarked on high‑intensity focused ultrasound (HIFU) therapy back in 2009, Professor Gong Xiaoming has kept up his persistent research for over a decade. His clinical focus lies in two prevalent and challenging gynecological conditions: uterine fibroids and adenomyosis. He keeps exploring, updating and innovating treatment protocols.
From the early‑stage clinical adoption of HIFU and magnetic‑field‑guided focused ultrasound (MgFUS) ablation, to the later‑day deployment and optimisation of microwave ablation, radiofrequency ablation and other non‑invasive ablation techniques, Professor Gong has always stayed at the forefront of the industry. He pursues safer, gentler treatment options tailored to women’s needs, laying a robust domestic foundation for gynecological non‑invasive therapy and setting international clinical benchmarks.
Uterine fibroids and adenomyosis affect hundreds of millions of women of child‑bearing age. For a long time, patients have suffered from recurring lesions, severe trauma and slow recovery following conventional open surgery, alongside risks of hysterectomy. Countless women endure both physical illness and fear of operations.
Many patients are troubled by chronic dysmenorrhea, abdominal pain and abnormal menstruation, which undermine their daily life, work and reproductive wellness. Nevertheless, anxiety over surgical trauma, high postoperative recurrence rates and hysterectomy stops them from receiving standard‑of‑care treatment.Having identified these clinical pain points and women’s physical‑and‑mental hardships, Professor Gong Xiaoming adheres to the core principle of prioritising patients’ maximum interests. He breaks conventional clinical mindsets and brings fresh perspectives on gynecological disease management.Unlike the traditional treatment goal of simply eliminating lesions, Professor Gong puts forward a revolutionary clinical concept. The primary goal for uterine fibroid management is the relief of symptoms and preservation of fertility, rather than the forced removal of fibroids.
Medically speaking, fibroids are prone to recur as long as the uterus remains intact. Blind pursuit of complete lesion removal often leads to overtreatment and impaired uterine function.Against this backdrop, Professor Gong’s team has abandoned one‑size‑fits‑all therapies and built a comprehensive, individualised treatment system covering non‑invasive ablation, vaginal surgery, laparoscopy, hysteroscopy and V‑NOTES.
During clinical consultations, the team conducts thorough assessments based on the patient’s age, symptom severity, fertility requirements and lesion conditions. They select the optimal long‑term treatment plan, reject generic protocols and overtreatment, and minimise surgical trauma and psychological distress.
Adenomyosis triggers far‑more‑agonising symptoms and poses greater clinical challenges, and Professor Gong’s breakthroughs have brought hope for critically‑ill patients.
Many patients describe adenomyosis‑related pain as more excruciating than childbirth. Discomfort persists beyond menstruation and wears patients down physically and mentally. Conventional open surgery carries substantial risks and high recurrence rates. Many patients endure relentless pain to preserve their uterus and avoid surgical injury.To tackle this clinical dilemma, Professor Gong Xiaoming’s team has advanced ablation‑technique applications and performed precise ultrasound‑guided and laparoscopy‑guided ablation procedures. This creates a novel minimally‑invasive alternative to hysterectomy for adenomyosis sufferers.
The scar‑free approach requires no uterine resection, delivers minimal trauma and enables fast recovery. It relieves refractory dysmenorrhea and halts lesion progression while preserving the uterus and female reproductive health. In particular, it offers a safe and effective uterus‑sparing fertility‑preserving pathway for patients planning pregnancy, enabling countless afflicted women to recover from chronic illness.More than ten years of dedicated practice have brought forth innovation rooted in solid expertise. Now Professor Gong carries his original aspiration onto the international stage and earns global acclaim.His appointment as Chair of the inaugural ISOGA Congress marks a new milestone in his academic career. It also signals worldwide recognition for China’s uterus‑sparing, individualised and minimally‑non‑invasive gynecological treatment philosophy.
Moving forward, led by Professor Gong Xiaoming, the Woyi Minimally‑Non‑Invasive Medicine Team will continue its research on uterine fibroid and adenomyosis management. The team will keep pace with international cutting‑edge technologies, optimise therapeutic schemes and spread evidence‑based health‑seeking awareness.With sophisticated skills and human‑centred medical services, the team will safeguard uterine health for numerous women, help them overcome surgical anxiety and chronic illness, and defend their right to health and fertility.As reported, the International Society of Obstetrics‑Gynecology Ablation (ISOGA) is an international non‑profit organisation co‑founded by top ablation specialists from over 20 countries. It commits itself to standardised clinical deployment and innovative advancement of obstetric and gynecological ablation technology.Through systematic technical training, cutting‑edge research and international academic exchanges, the society promotes minimally‑non‑invasive ablation therapies among obstetrician‑gynecologists worldwide, elevates global minimally‑invasive gynecology standards and benefits female patients across the globe.
For further information about ISOGA, please visit its official website: www.isoga.org